(Q38078839)

28 August 2017

1 reference

title

Impact of diabetes and its treatments on skeletal diseases (English)

1 reference

28 August 2017

Wenbo Yan

1

1 reference

PubMed ID

23377889

28 August 2017

Xin Li

series ordinal

2

1 reference

28 August 2017

2 February 2013

1 reference

28 August 2017

Frontiers of medicine

1 reference

28 August 2017

7

1 reference

28 August 2017

1

1 reference

28 August 2017

81-90

1 reference

https://scigraph.springernature.com/pub.10.1007/s11684-013-0243-9

28 August 2017

0 references

cites work

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Cellular and molecular mechanisms of bone remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Cellular mechanisms of bone remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Disorders of bone remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

21 January 2018

The amazing osteocyte

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Osteocyte: the unrecognized side of bone tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

An estimate of the worldwide prevalence and disability associated with osteoporotic fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Diabetes mellitus and the risk of non-vertebral fractures: the Tromsø study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Osteoporosis in patients with diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Bone, sweet bone--osteoporotic fractures in diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Methods for assessing bone quality: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Older women with diabetes have a higher risk of falls: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Older individuals with diabetes have an increased risk of recurrent falls: analysis of potential mediating factors: the Longitudinal Ageing Study Amsterdam

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Risk factors for falls in older disabled women with diabetes: the women's health and aging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Prevalence of Falls and Its Associated Factors among Elderly Diabetes in a Tertiary Center, Malaysia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Unique responses of stem cell-derived vascular endothelial and mesenchymal cells to high levels of glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Effect of age and diabetes on the response of mesenchymal progenitor cells to fibrin matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Problems associated with glucose toxicity: role of hyperglycemia-induced oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Hyperglycemia-induced oxidative stress in diabetic complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Pentosidine effects on human osteoblasts in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Pentosidine and increased fracture risk in older adults with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

The osteoblast: an insulin target cell controlling glucose homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

The central regulation of bone mass, the first link between bone remodeling and energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Biology without walls: the novel endocrinology of bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Bone endocrine regulation of energy metabolism and male reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Reciprocal regulation of bone and energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Endocrine regulation of energy metabolism by the skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

The mutual dependence between bone and gonads

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Reduced serum osteocalcin concentrations are associated with type 2 diabetes mellitus and the metabolic syndrome components in postmenopausal women: the crosstalk between bone and energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Relationship between serum osteocalcin and glycaemic variability in Type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Serum osteocalcin/bone-specific alkaline phosphatase ratio is a predictor for the presence of vertebral fractures in men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Osteoporosis prevention, diagnosis, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Effect of an oral glucose load on PTH, 250HD3, calcium, and phosphorus homeostasis in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Down-regulation of human osteoblast PTH/PTHrP receptor mRNA in end-stage renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Intermittent parathyroid hormone fails to stimulate osseointegration in diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

The impact of osteoarthritis in the United States: a population-health perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Prevalence of diagnosed arthritis and arthritis-attributable activity limitation among adults with and without diagnosed diabetes: United States, 2008-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Diabetes causes the accelerated loss of cartilage during fracture repair which is reversed by insulin treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Increased fasting serum glucose concentration is associated with adverse knee structural changes in adults with no knee symptoms and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Accumulation of advanced glycation endproducts reduces chondrocyte-mediated extracellular matrix turnover in human articular cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: Role of the receptor for advanced glycation end products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Advanced glycation end products increases matrix metalloproteinase-1, -3, and -13, and TNF-alpha in human osteoarthritic chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Effects of advanced glycation end products on the expression of COX-2, PGE2 and NO in human osteoarthritic chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Advanced glycation end products induce the expression of interleukin-6 and interleukin-8 by receptor for advanced glycation end product-mediated activation of mitogen-activated protein kinases and nuclear factor-κB in human osteoarthritis chondrocyt

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Akt1 in osteoblasts and osteoclasts controls bone remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Effects of a new oral hypoglycaemic agent (CS-045) on metabolic abnormalities and insulin resistance in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Bone is a target for the antidiabetic compound rosiglitazone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Thiazolidinedione use and bone loss in older diabetic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Thiazolidinedione use and the longitudinal risk of fractures in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Osteoblast-targeted overexpression of PPARγ inhibited bone mass gain in male mice and accelerated ovariectomy-induced bone loss in female mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

PPAR-gamma regulates osteoclastogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Rosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Thiazolidinediones induce osteocyte apoptosis and increase sclerostin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Metformin regulates osteoblast and adipocyte differentiation of rat mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Effect of the anti-diabetic drug metformin on bone mass in ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Effect of metformin on bone marrow progenitor cell differentiation: in vivo and in vitro studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

AMP-activated protein kinase attenuates Wnt/β-catenin signaling in human osteoblastic Saos-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Metformin induces osteoblast differentiation via orphan nuclear receptor SHP-mediated transactivation of Runx2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Metformin reverses the deleterious effects of high glucose on osteoblast function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Metformin reverts deleterious effects of advanced glycation end-products (AGEs) on osteoblastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Exercise training in high-risk ethnic populations with type 2 diabetes: a systematic review of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Effectiveness of interventions for reducing diabetes and cardiovascular disease risk in people with metabolic syndrome: systematic review and mixed treatment comparison meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Effects of ground and joint reaction force exercise on lumbar spine and femoral neck bone mineral density in postmenopausal women: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Exercise effects on bone mineral density in older adults: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0243-9

Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women

21 January 2018

1 reference

12 December 2020

Increased insulin responsiveness after CS-045 treatment in diabetes associated with Werner's syndrome

1 reference

12 December 2020

[Osteocytic bone remodeling: history of the problem, morphological markers]

1 reference

12 December 2020

Intensive insulin therapy and bone mineral density in type 1 diabetes mellitus: a prospective study

1 reference

12 December 2020

Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men

1 reference

12 December 2020

Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation

1 reference

12 December 2020

Role of glucose as a modulator of anabolic and catabolic gene expression in normal and osteoarthritic human chondrocytes

1 reference

12 December 2020

Risk factors for fractures and falls in older women with type 2 diabetes mellitus

1 reference

12 December 2020

Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats

1 reference

12 December 2020

Thiazolidinediones on PPARγ: The Roles in Bone Remodeling

1 reference

12 December 2020

Bone mineral density and fracture risk in patients with type 1 and type 2 diabetes mellitus.

1 reference

12 December 2020

Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk

1 reference

12 December 2020

Increased incidence of vertebral fracture in older female hemodialyzed patients with type 2 diabetes mellitus

1 reference

12 December 2020

Influence of age, sex, and insulin on osteoblast function: osteoblast dysfunction in diabetes mellitus

1 reference

12 December 2020

Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus

1 reference

12 December 2020

CS-045, a new oral antidiabetic agent, stimulates fructose-2,6-bisphosphate production in rat hepatocytes

1 reference

12 December 2020

Protective effect of metformin on periapical lesions in rats by decreasing the ratio of receptor activator of nuclear factor kappa B ligand/osteoprotegerin

1 reference

12 December 2020

Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2.

1 reference

12 December 2020

10.1007/S11684-013-0243-9

Identifiers

DOI

1 reference

PubMed ID

23377889

Dimensions Publication ID

28 August 2017

0 references

1 reference

PubMed ID

23377889